These finding may indicate that activating KIR2DS1 and KIR2DS2 confer protection against developing severe disease while KIR2DS4del and inhibitory KIR2DL3 increase the risk of severe disease in patients with COVID-19. The gene discussed is KIR2DL3; the disease is COVID-19.